Research Projects & Grants

For Profit Organization

  • USE OF THE IMPELLA ECP™ IN PATIENTS UNDERGOING AN ELECTIVE OR URGENT HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION, Role: PI, ABIOMED, Inc., (07/2024 - 07/2025) Status: Approved
  • SELUTION SLR™ 014 ISR: A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 Drug Eluting Balloon in the Treatment of Subjects with In-stent Restenosis, Role: Investigator, MedAlliance, (06/2024 - 06/2025) Status: Approved
  • SSO2 THERAPY: AMIHOT III STUDY: A MULTI-CENTER RANDOMIZED POST-APPROVAL EVALUATION OF THE DELIVERY OF INTRACORONARY HYPEROXEMIC SUPERSATURATED OXYGEN THERAPY FOR 60 MINUTES IN ANTERIOR ACUTE MYOCARDIAL INFARCTION PATIENTS WITH SUCCESSFUL REPERFUSION (VIA PCI) = SIX HOURS AFTER SYMPTOM ONSET COMPARED TO STANDARD THERAPY, Role: Investigator, TherOx, Inc., (05/2024 - 05/2025) Status: Approved
  • Ultrasound-based renal sympathetic denervation as adjunctive upstream therapy during atrial fibrillation ablation: a pilot study (ULTRA-HFIB), Role: Investigator, ReCor Medical, Inc., (01/2025 - 01/2026) Status: Approved
  • Impella®-Supported PCI in High-Risk Patients with Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial, Role: PI, ABIOMED, Inc., (01/2025 - 01/2026) Status: Approved
  • Equity in Modifying Plaque Of WomEn with UndeRtreated Calcified Coronary Artery Disease (EMPOWER CAD), Role: Investigator, Shockwave Medical, Inc., (11/2023) Status: Approved
  • RESTORE EF study, Role: PI, ABIOMED, Inc., (11/2019 - 09/2021) Status: Completed
  • ARTEMIS- Effects of ziltivekimab versus placebo on cardiovascular outcomes in patients with acute myocardial infarction, Role: PI, Novo Nordisk Pharmaceuticals Inc., (10/2024 - 10/2025) Status: Approved

Internal

  • HUD: PK Papyrus Covered Coronary Stent System, Role: Investigator, LLU Dept. of Medicine, (05/2024 - 05/2025) Status: Approved
  • AHA-Cardiogenic Shock Registry, Role: PI, LLU Dept. of Medicine, (05/2023) Status: Approved
  • Evaluation of clinical impact of non-invasive hemodynamic monitoring to optimize preventive care of heart failure patients, Role: Investigator, LLU Dept. of Anesthesiology, (09/2020 - 09/2021) Status: Completed
  • National cardiogenic shock initiative, Role: PI, LLU Dept. of Cardiology, (07/2020 - 07/2021) Status: Completed
  • A Retrospective Analysis and Review of Patients Undergoing Impella, a Temporary Left Ventricular Support Device, Implantation for Complex Coronary Intervention or Cardiogenic Shock, Role: PI, LLU Dept. of Medicine, (04/2020) Status: Approved

Non-Profit Organization

  • Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock (CERAMICS Study), Role: PI, Henry Ford Health System, (03/2023) Status: Approved